Skip to main content
Log in

Plasma protein binding of furosemide in the elderly

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The protein binding of furosemide was investigated in plasma from 22 old and 11 young subjects by equilibrium dialysis. The unbound fraction of furosemide was 3.16% in plasma from the elderly and 1.71% in plasma from the young. A significant correlation was found between the unbound fraction of furosemide and the plasma concentration of albumin. The average number of binding sites was 3.8 (elderly) and 2.7 (young) 10−6 mol/g albumin. The average association constant (K) was 4.3 (elderly) and 4.2 (young) 105 M−1. By increasing the concentration of furosemide up to 200 µg/ml buffer the unbound fraction of the drug rose to 5.2% (elderly) and 3.5% (young).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  1. Greenblatt DJ, Sellers EM, Shader RI (1982) Drug disposition in old age. N Engl J Med 306: 1081–1088

    Google Scholar 

  2. Jusko WJ, Gretch M (1976) Plasma and tissue protein binding of drugs in pharmacokinetics. Drug Metab Rev 5: 43–140

    Google Scholar 

  3. Gibaldi M, Koup JR (1981) Pharmacokinetic concepts. Drug binding, apparent volume of distribution and clearance. Eur J Clin Pharmacol 20: 299–305

    Google Scholar 

  4. Levy G (1980) Influence of plasma protein binding on the renal clearance of drugs. J Pharm Sci 69: 482–483

    Google Scholar 

  5. Rowland M (1984) Protein binding and drug clearance. Clin Pharmacokinet 9 [Suppl 1]: 10–17

    Google Scholar 

  6. Benet LZ (1979) Pharmacokinetics/pharmacodinamics of furosemide in man: A review. J Pharmacokinet Biopharm 7: 1–27

    Google Scholar 

  7. Beermann B, Groschinsky-Grind M (1980) Clinical pharmacokinetics of diuretics. Clin Pharmacokinet 5: 221–245

    Google Scholar 

  8. Cutler RE, Blair AD (1979) Clinical pharmacokinetics of frusemide. Clin Pharmacokinet 4: 279–296

    Google Scholar 

  9. Dybkaer R, Lauritzen M, Krakauer R (1981) Relative reference values for clinical chemical and haemathological quantities in “healthy” elderly peaple. Acta Med Scand 209: 1–9

    Google Scholar 

  10. Pacifici GM, Viani A, Taddeucci-Brunelli G (1987) Serum protein binding of furosemide in newborn infants and children. Dev Pharmacol Ther (in press)

  11. Verbeeck RK, Cardinal JA, Wallace SM (1984) Effects of age and sex on the plasma binding of acidic and basic drugs. Eur J Clin Pharmacol 27: 91–97

    Google Scholar 

  12. Andreasen F, Hansen U, Husted SE, Mogensen CE, Pedersen EB (1984) The influence of age on renal and extrarenal effects of frusemide. Br J Clin Pharmacol 18: 65–74

    Google Scholar 

  13. Kerremans AdLM, van Baars YTH, van Ginneken CAM, Gribnau FWJ (1983) Furosemide kinetics and dinamics in aged patients. Clin Pharmacol Ther 34: 181–189

    Google Scholar 

  14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin fenol reagent. J Biol Chem 193: 265–275

    Google Scholar 

  15. Mancini G, Carbonara AO, Heremans JF (1965) Immunological quantitation of antigens by single radial immunodiffusion. Immunochemistry 2: 235–254

    Google Scholar 

  16. Di Salle E, Pacifici GM, Morselli PL (1974) Studies on plasma protein binding of carbamazepine. Pharmacol Res Commun 6: 193–202

    Google Scholar 

  17. Prandota J, Pruitt AW (1975) Furosemide binding to human albumin and plasma of nephrotic children. Clin Pharmacol Ther 17: 159–166

    Google Scholar 

  18. Rane A, Villeneuve JP, Stone WJ, Nies AS, Wilkinson GR, Branch RA (1978) Plasma binding and disposition of furosemide in the nephrotic syndrome and in uremia. Clin Pharmacol Ther 24: 199–207

    Google Scholar 

  19. Sjoholm I, Ekman B, Kober A, Ljungstedt-Pahlman I, Seiving B, Sjodin T (1979) Binding of drugs to human serum albumin: XI. Mol Pharmacol 16: 767–777

    Google Scholar 

  20. Rudman D, Bixler TJ, Del Rio AE (1971) Effects of FFA on binding of drugs by bovine serum albumin, by human serum albumin, and by rabbit serum. J Pharmacol Exp Ther 176: 261–272

    Google Scholar 

  21. Gugler R, Shoemann DW, Azarnoff DL (1974) Effect of in vivo elevation of free fatty acids on protein binding of drugs. Pharmacology 12: 160–165

    Google Scholar 

  22. Branch RA (1983) Role of binding in distribution of furosemide: where is nonrenal clearance? Fed Proc 42: 1699–1702

    Google Scholar 

  23. Hall S, Rowland M (1985) Influence of fraction unbound upon the renal clearance of furosemide in the isolated perfused rat kidney. J Pharmacol Exp Ther 232: 263–268

    Google Scholar 

  24. Friedman SA, Raizner AE, Rosen H, Solomon NA, Sy W (1972) Functional defects in the aging kidney. Ann Intern Med 76: 41–45

    Google Scholar 

  25. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW (1976) The effects of age on creatinine clearance in man: A cross-sectional and longitudinal study. J Gerontol 31: 155–163

    Google Scholar 

  26. Pacifici GM, Viani A, Taddeucci-Brunelli G, Rizzo G, Carrai M, Schulz HU (1986) Effects of development, aging, renal and hepatic insufficiency as well as haemodialysis on the plasma concentrations of albumin and α1-acid glycoprotein. Ther Drug Monit 8: 259–263

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pacifici, G.M., Viani, A., Schulz, H.U. et al. Plasma protein binding of furosemide in the elderly. Eur J Clin Pharmacol 32, 199–202 (1987). https://doi.org/10.1007/BF00542196

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00542196

Key words

Navigation